TSBX Turnstone Biologics Corporation: Multiplikator nilai perusahaan marang pendapatan

Logo perusahaan publik Turnstone Biologics Corp (TSBX)

The reliability of Turnstone Biologics (TSBX) therapy relies on strict adherence to temperature controls during the transportation of viral drugs. The EV/Sales history demonstrates the valuation dynamics of the business excluding debt, where the value of characterizes this level. Diversification of clinical trial targets reduces regulatory risks, while high demand for solid tumor treatment facilitates the expansion of the partner medical center network.

Nilai perusahaan marang pendapatan: Turnstone Biologics Corporation (TSBX) kanggo 04.07.2022 - 20.11.2026

Turnstone Biologics Corporation - rincian analitis lan metrik utama (TSBX)

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:Turnstone Biologics Corp TSBX
Sampel barang Turnstone Biologics Corp

The stability of this metric confirms the long-term reliability of the issuer, reflecting the market value of the business minus net debt per unit of revenue. By analyzing the enterprise value-to-annual revenue multiple, the investor assesses the capitalization efficiency of Turnstone Biologics (TSBX) within the context of its expansion into the TIL therapy sector for treating solid tumors and its capture of the immuno-oncology niche.

Analisis pesaing Turnstone Biologics

IBRX (immunitybio.com) - Rasio nilai perusahaan marang pendapatan|Immunocore Corp (IMCR) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Janux Pharma (JANX)|Nilai perusahaan marang pendapatan RCUS|ZYME - Rasio nilai perusahaan marang dodolan|Nilai perusahaan marang pendapatan TNGX (Tango Pharma)|Koefisien nilai perusahaan marang pendapatan IOVA|Multiplikator EV/Sales IMTX (Immatics)|Nilai bisnis marang pendapatan XNCR|compasstherapeutics.com - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Replimune Inc.|Lyell Immunopharma (LYEL) - Rasio nilai perusahaan marang pendapatan|Innate Pharma S.A. - Nilai bisnis marang pendapatan|PYXS (Pyxis) - Multiplikator EV/Sales|Multiplikator EV/Sales cgen.com|Rasio nilai perusahaan marang pendapatan IO Biotech (IOBT)|STRO: Nilai perusahaan marang volume dodolan|MiNK Therapeutics Inc. - Nilai perusahaan marang pendapatan|werewolftx.com (HOWL) - Multiplikator nilai perusahaan marang pendapatan|Immix Biopharma Inc. - Multiplikator EV/Sales|ALXO - Multiplikator EV/Sales|CUE: Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan PDSB|Rasio nilai perusahaan marang pendapatan Sonnet BioTherapeutics Holdings|MAIA Biotechnology (MAIA) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales LIMN|Multiplikator EV/Sales Lava Tx (LVTX)|Multiplikator EV/Sales NXTC (NextCure Corporation)|Nilai bisnis marang pendapatan LPTX|INTS - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Sensei Biotherapeutics Inc SNSE|TOVX: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Gritstone Bio (GRTS)|KA (Kineta Corp) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan NEXI (NexImmune Corp)|Nilai perusahaan marang pendapatan VCNX (Vaccinex, Inc.)|Koefisien nilai perusahaan marang pendapatan HARP